Differences in HIV-specific T cell responses between HIV-exposed and -unexposed HIV-seronegative individuals
- PMID: 21270166
- PMCID: PMC3067859
- DOI: 10.1128/JVI.02444-10
Differences in HIV-specific T cell responses between HIV-exposed and -unexposed HIV-seronegative individuals
Abstract
HIV-1-specific T lymphocyte responses in individuals exposed to HIV-1 but who remain persistently seronegative (HESNs) have been reported in some but not all previous studies. This study was designed to resolve unequivocally the question of whether HESNs make HIV-1-specific T cell responses. We performed a blind investigation to measure HIV-1-specific T cell responses in both HIV-1-serodiscordant couples and HIV-1-unexposed seronegative controls (HUSNs). We found low-frequency HIV-1-specific T cells in both HESNs and HUSNs but show that the response rates were higher over time in the former (P = 0.01). Furthermore, the magnitudes of the HIV-1-specific T cell responses were significantly higher among responding HESNs than among HUSNs over time (P = 0.002). In both groups, responses were mediated by CD4 T cells. The responses were mapped to single peptides, which often corresponded to epitopes restricted by multiple HLA-DR types that have previously been detected in HIV-1-infected patients. HIV-1-specific T cell responses in HUSNs and some HESNs likely represent cross-reactivity to self or foreign non-HIV-1 antigens. The significantly greater T cell responses in HESNs, including in two who were homozygous for CCR5Δ32, demonstrates that HIV-1-specific T cell responses can be induced or augmented by exposure to HIV-1 without infection.
Figures


Similar articles
-
Vitamin D treatment of peripheral blood mononuclear cells modulated immune activation and reduced susceptibility to HIV-1 infection of CD4+ T lymphocytes.PLoS One. 2019 Sep 24;14(9):e0222878. doi: 10.1371/journal.pone.0222878. eCollection 2019. PLoS One. 2019. PMID: 31550271 Free PMC article.
-
Identification and antigenicity of broadly cross-reactive and conserved human immunodeficiency virus type 1-derived helper T-lymphocyte epitopes.J Virol. 2001 May;75(9):4195-207. doi: 10.1128/JVI.75.9.4195-4207.2001. J Virol. 2001. PMID: 11287569 Free PMC article.
-
HLA-DR-restricted peptides identified in the Nef protein can induce HIV type 1-specific IL-2/IFN-gamma-secreting CD4+ and CD4+ /CD8+ T cells in humans after lipopeptide vaccination.AIDS Res Hum Retroviruses. 2007 Mar;23(3):427-37. doi: 10.1089/aid.2006.0075. AIDS Res Hum Retroviruses. 2007. PMID: 17411376 Clinical Trial.
-
Multiple Approaches for Increasing the Immunogenicity of an Epitope-Based Anti-HIV Vaccine.AIDS Res Hum Retroviruses. 2015 Nov;31(11):1077-88. doi: 10.1089/AID.2015.0101. Epub 2015 Aug 13. AIDS Res Hum Retroviruses. 2015. PMID: 26149745 Review.
-
Natural Immunity to HIV: A Template for Vaccine Strategies.Viruses. 2018 Apr 23;10(4):215. doi: 10.3390/v10040215. Viruses. 2018. PMID: 29690575 Free PMC article. Review.
Cited by
-
HIV vaccines: can CD4+ T cells be of help?Hum Vaccin Immunother. 2012 Dec 1;8(12):1795-8. doi: 10.4161/hv.21760. Epub 2012 Aug 21. Hum Vaccin Immunother. 2012. PMID: 22906935 Free PMC article.
-
Heterologous Immunity: Role in Natural and Vaccine-Induced Resistance to Infections.Front Immunol. 2019 Nov 8;10:2631. doi: 10.3389/fimmu.2019.02631. eCollection 2019. Front Immunol. 2019. PMID: 31781118 Free PMC article. Review.
-
Regulatory T-Cell Activity But Not Conventional HIV-Specific T-Cell Responses Are Associated With Protection From HIV-1 Infection.J Acquir Immune Defic Syndr. 2016 Jun 1;72(2):119-28. doi: 10.1097/QAI.0000000000000919. J Acquir Immune Defic Syndr. 2016. PMID: 26656786 Free PMC article. Clinical Trial.
-
Cellular immune correlates analysis of an HIV-1 preexposure prophylaxis trial.Proc Natl Acad Sci U S A. 2015 Jul 7;112(27):8379-84. doi: 10.1073/pnas.1501443112. Epub 2015 Jun 22. Proc Natl Acad Sci U S A. 2015. PMID: 26100867 Free PMC article.
-
Comparison of sexual behavior and HIV risk between two HIV-1 serodiscordant couple cohorts: the CHAVI 002 study.PLoS One. 2012;7(5):e37727. doi: 10.1371/journal.pone.0037727. Epub 2012 May 22. PLoS One. 2012. PMID: 22629447 Free PMC article.
References
-
- Adams, S. L., R. A. Biti, and G. J. Stewart. 1997. T-cell response to HIV in natural infection: optimized culture conditions for detecting responses to gag peptides. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 15:257-263. - PubMed
-
- Alimonti, J. B., et al. 2006. Characterization of CD8 T-cell responses in HIV-1-exposed seronegative commercial sex workers from Nairobi, Kenya. Immunol. Cell Biol. 84:482-485. - PubMed
-
- Appay, V., et al. 2002. Persistent HIV-1-specific cellular responses despite prolonged therapeutic viral suppression. AIDS 16:161-170. - PubMed
-
- Barretina, J., et al. 2000. Evaluation of the putative role of C-C chemokines as protective factors of HIV-1 infection in seronegative hemophiliacs exposed to contaminated hemoderivatives. Transfusion 40:461-467. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials